TEXAS HEALTH CLEBURNE — History
CCN 450148 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$85M
Latest Revenue (FY2022)
+12.4%
Revenue CAGR (3yr)
0.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $67M | $77M | $85M | +10.0% | +12.4% |
| Operating Expenses | $71M | $78M | $85M | +8.3% | +9.0% |
| Operating Margin | -6.2% | -1.4% | 0.1% | +106.1% | +0.0% |
| Net Income | $-4M | $-1M | $0M | +106.7% | +0.0% |
| Licensed Beds | 92 | 75 | 75 | +0.0% | -9.7% |
| Total Patient Days | 10,814 | 12,334 | 13,868 | +12.4% | +13.2% |
| Medicare Day % | 24% | 24% | 24% | -0.1% | -0.4% |
| Medicaid Day % | 2% | 2% | 2% | -10.2% | -17.8% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +26.3% ($67M → $85M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.4%
This Hospital
+7.6%
State Avg
Latest Margin
0.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $94M | 3.2% |
| FY2024 (proj) | $103M | 6.4% |
| FY2025 (proj) | $111M | 9.5% |